Grzegorz Korpanty

Prognostic and predictive effects of TP53 co-mutation in patients with EGFR -mutated non-small cell lung cancer (NSCLC)

Catherine Labbé, Michael Cabanero, Grzegorz Korpanty et al. · Lung Cancer · 2017 · 246 citations

Medicine, Molecular Genetics, Oncology +15

Monitoring Response to Anticancer Therapy by Targeting Microbubbles to Tumor Vasculature

Grzegorz Korpanty, Juliet G. Carbon, Paul Grayburn et al. · Clinical Cancer Research · 2007 · 245 citations · Full text

Medicine, Oncology, Pharmacology +17

ALK-Rearranged Non–Small-Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism

Alona Zer, Mor Moskovitz, David Hwang et al. · Clinical Lung Cancer · 2016 · 100 citations

Medicine, Genetics, Oncology +14

Targeting vascular endothelium with avidin microbubbles

Grzegorz Korpanty, Paul Grayburn, Ralph V. Shohet et al. · Ultrasound in Medicine & Biology · 2005 · 87 citations

Pharmacy, Biomedical Engineering, Pharmaceutics +11

Forced Expression of MMP9 Rescues the Loss of Angiogenesis and Abrogates Metastasis of Pancreatic Tumors Triggered by the Absence of Host SPARC

Shanna A. Arnold, E. Mira, Sabeeha Muneer et al. · Experimental Biology and Medicine · 2008 · 68 citations

Medicine, Cancer Biology, Oncology +17